Nicht aus der Schweiz? Besuchen Sie lehmanns.de

The Use and Misuse of Psychiatric Drugs (eBook)

An Evidence-Based Critique

(Autor)

eBook Download: PDF
2010 | 1. Auflage
224 Seiten
John Wiley & Sons (Verlag)
978-0-470-66662-3 (ISBN)

Lese- und Medienproben

The Use and Misuse of Psychiatric Drugs - Joel Paris
Systemvoraussetzungen
45,99 inkl. MwSt
(CHF 44,90)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
"Dr. Paris has written an honest, balanced presentation of the ways
in which psychiatric drugs are evaluated and prescribed. He
highlights the complexity of the task, the limits of what is known
and the mixed picture that research often produces. His conclusions
are refreshing because they are built from an even-handed,
pragmatic assessment of the empirical evidence. The result is a
stimulating look at the world of treatments for emotional disorders
that acknowledges the usefulness of both biological and
psychosocial explanations where appropriate. His recommendations
provide helpful roadmaps for patients, practitioners and
researchers alike. The book is sure to serve as a welcome catalyst
for the continuing debates about which treatments are likely to
produce the best outcomes."

--Roger P. Greenberg, Ph.D. Distinguished Professor and
Head, Psychology Division Dept. of Psychiatry & Behavioral
Science SUNY Upstate Medical University, NY, USA

The message of this book is that psychiatrists have some very
good drugs, but can expect bad results when they are over-used,
prescribed outside of evidence-based indications, or given to the
wrong patients. While acknowledging that many current agents are
highly effective and have revolutionized the treatment of certain
disorders, Joel Paris criticizes their use outside of an evidence
base. Too many patients are either over-medicated or are
misdiagnosed to justify aggressive treatment. Dr. Paris calls for
more government funding of clinical trials to establish, without
bias, the effectiveness of these agents. He has written this book
for practitioners and trainees to show that scientific evidence
supports a more cautious and conservative approach to drug
therapy.

After describing the history of psychopharmacology, including
its early successes, Dr. Paris reviews the relationship between
psychiatry and the pharmaceutical industry. This problem has
received considerable popular attention in recent years and Dr.
Paris documents initiatives to increase transparency and decrease
the influence of pharmaceutical marketing on diagnosis and
prescribing habits.

Dr Paris then examines some major controversies. One is the fact
that newer drugs have not been shown to be superior to older
agents. Another is that while the number of prescriptions for
antidepressants has increased dramatically, meta-analyses show that
their value is more limited than previously believed. Still another
is the widespread prescription of mood stabilizers and
antipsychotic drugs for patients, including children and
adolescents, who do not have bipolar illness. Polypharmacy is an
especially contentious area: very few drug combinations have been
tested in clinical trials, yet many patients end up on a cocktail
of powerful drugs, each with its own side effects.

Dr Paris briefly considers alternatives to pharmacology and
again calls for more clinical trials of these approaches. He also
discusses the current trend to medicalizing what many would
describe as normal distress and states succinctly: Some things in
life are worth being upset about.

Joel Paris is a professor of psychiatry and former department chair who has taught in a large university for 40 years. A researcher (with over 150 publications), a clinician, and the editor of a major journal, he has written/edited 12 books. He writes in a way that can readily be understood by clinicians. Joel Paris is an active researcher, primarily in personality disorders and child & adolescent psychiatry, and both this and his considerable practical expertise enable him to argue intelligently both for and against the use of psychotropic medications. His background as a medical investigator and broad experience in teaching young psychiatrists about the use of drugs help him to make neutral judgments about complex issues.

Foreword.

Introduction.

Part I OVERVIEW.

1 The History of Psychopharmacology.

2 The Science of Psychopharmacology.

3 The Pharmaceutical Industry.

Part II DRUGS IN PRACTICE.

4 Antipsychotics: For Better or For Worse.

5 Mood Stabilizers and Mood Instability.

6 Antidepressants.

7 Prescribing for Children and Adolescents.

8 Polypharmacy.

Part III PERSPECTIVES.

9 Alternatives to Drugs.

10 Medicalizing Distress.

11 The Future of Psychopharmacology.

References.

Index.

"The Use and Misuse of Psychiatric Drugs
deserves a place in every health sciences library."
(Metapsychology Online Reviews, 8 January 2013)

"In the book's foreword, Tyrer describes this book as a
''well balanced sober account of a serious issue that
affects almost all of us in one way or another'' and I
would agree with that. The book is well written, easy to read, and
makes good bedtime reading despite the serious nature of its topic.
Epidemiologists will find it useful as background to the use of
these medications, even if observational studies were neglected.
... Paris is not afraid to tackle controversial topics and make
forceful
statements about issues where improvement is needed. I highly
recommend this book to anyone who would like to know more about
this topic." (Annals of Epidemiology, 2012)

Erscheint lt. Verlag 6.7.2010
Sprache englisch
Themenwelt Medizin / Pharmazie Gesundheitsfachberufe
Medizin / Pharmazie Medizinische Fachgebiete Psychiatrie / Psychotherapie
Schlagworte Clinical psychology • Klinische Psychologie • Medical Science • Medizin • Pharmacology & Pharmaceutical Medicine • Pharmakologie • Pharmakologie u. Pharmazeutische Medizin • Psychiatrie • Psychologie • Psychology • Psychopharmacology • Psychopharmaka • Psychopharmakologie
ISBN-10 0-470-66662-5 / 0470666625
ISBN-13 978-0-470-66662-3 / 9780470666623
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 837 KB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich